| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1998) |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | 3Z6W3S36X5 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTISENSE INHIBITOR | Major intermediate early region 2 mRNA antisense inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cytomegalovirus Retinitis | 2 | D017726 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1201512 |
| FDA SRS | 3Z6W3S36X5 |
| PubChem | 71587550 |
CONTENTS